June National Provider Data Summary
The following 2 Trusts did not submit any RTT pathway data:
Royal Free London NHS Foundation Trust (RAL)
Mid Essex Hospital Services NHS Trust (RQ8)
As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to June 2018.
Waiting List Size
As the below graph demonstrates, from June 2018 to June 2019 the total waiting list size increased from 4,113,849 to 4,395,351, an increase of 281,502 (6.84%).
Below is a table showing each reporting Trusts variance in waiting list size from March 2019 to June 2019, sorted by percentage variance (please click to view the whole table).
52 Week Waiters
The below heatmap shows how the number of 52-week waiters has changed nationally, with areas such as the East Midlands and South managing to reduce their number of 52-week waiters.
Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2019 to June 2019, sorted by percentage variance (please click to view the whole table).
Changes to the Individual Specialties
In regard to the waiting list size of the individual specialties:
Other went from having the highest increase to the largest decrease in the waiting list size, going from 928,657 to 925,459 a decrease of 3,198 pathways (0.34%).
Gastroenterology also saw a large decrease in the waiting list size going from 227,256 to 224,062 a decrease of 3,194 pathways (1.40%).
ENT and Gynaecology both saw a high increase of the waiting list size with ENT going from 316,767 to 319,890, an increase of 3,123 pathways (0.98%) and Gynaecology going from 287,067 to 288,688, an increase of 1,621 pathways (0.56%).
Dermatology, as a single specialty saw the largest increase and percentage increase in waiting list size, going from 213,524 to 220,661 with a percentage increase of 3.34%.
At the end of June 2019, 86.3% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.
The number of RTT patients waiting to start treatment at the end of June 2019 was 4.4 million patients. Of those, 1,089 patients were waiting more than 52 weeks.
For patients waiting to start treatment at the end of June 2019, the median waiting time was 7.5 weeks. The 92nd percentile waiting time was 22.4 weeks.
During June 2019, 289,203 RTT patients started admitted treatment and 1,064,589 started non-admitted treatment (completed pathways).